Suppr超能文献

肌强直性营养不良 1 型和慢性疼痛的面肩肱型肌营养不良症患者的疼痛位置和强度影响其功能。

Pain location and intensity impacts function in persons with myotonic dystrophy type 1 and facioscapulohumeral dystrophy with chronic pain.

机构信息

Unit for the Study and Treatment of Pain-ALGOS, Centre de Recerca en Avaluació i Mesura del Comportament, Institut d'Investigació Sanitria Pere Virgili, Universitat Rovira i Virgili, Carretera de Valls s/n, 43007 Tarragona, Catalonia, Spain.

出版信息

Muscle Nerve. 2014 Jun;49(6):900-5. doi: 10.1002/mus.24079.

Abstract

INTRODUCTION

We examined the effects of pain site and intensity on function in patients with myotonic dystrophy type 1 (DM1) and facioscapulohumeral muscular dystrophy (FSHD) and chronic pain.

METHODS

Questionnaires assessing pain sites, pain extent (number of sites), pain intensity, and pain interference were completed by 182 individuals with DM1 (43%) or FSHD (57%) and chronic pain.

RESULTS

There was a positive association between pain extent and intensity with pain interference, and a negative association with psychological functioning in both DM1 and FSHD. Pain intensity at specific sites had differential impact beyond the effects of pain intensity alone. Head pain intensity independently affected psychological functioning, whereas leg, foot, hip, and knee pain contributed independently to the prediction of pain interference.

CONCLUSIONS

Pain site and intensity differentially modulates the effect of chronic pain on function in DM1 and FSHD patients. Researchers and clinicians should consider these factors when assessing and treating pain.

摘要

简介

我们研究了疼痛部位和强度对 1 型肌强直性营养不良(DM1)和面肩肱型肌营养不良症(FSHD)伴慢性疼痛患者功能的影响。

方法

通过问卷调查评估了 182 名患有 DM1(43%)或 FSHD(57%)和慢性疼痛的个体的疼痛部位、疼痛范围(部位数量)、疼痛强度和疼痛干扰。

结果

在 DM1 和 FSHD 中,疼痛范围和强度与疼痛干扰呈正相关,与心理功能呈负相关。特定部位的疼痛强度除了对疼痛强度的影响外,还具有不同的影响。头部疼痛强度独立影响心理功能,而腿部、脚部、臀部和膝盖疼痛则独立影响疼痛干扰的预测。

结论

疼痛部位和强度会对 DM1 和 FSHD 患者的慢性疼痛对功能的影响产生不同的调节作用。研究人员和临床医生在评估和治疗疼痛时应考虑这些因素。

相似文献

2
Chronic pain in persons with myotonic dystrophy and facioscapulohumeral dystrophy.
Arch Phys Med Rehabil. 2008 Feb;89(2):320-8. doi: 10.1016/j.apmr.2007.08.153.
3
Medication adherence in patients with myotonic dystrophy and facioscapulohumeral muscular dystrophy.
J Neurol. 2016 Dec;263(12):2528-2537. doi: 10.1007/s00415-016-8300-3. Epub 2016 Oct 12.
5
Impact of biopsychosocial factors on chronic pain in persons with myotonic and facioscapulohumeral muscular dystrophy.
Am J Hosp Palliat Care. 2009 Aug-Sep;26(4):308-19. doi: 10.1177/1049909109335146. Epub 2009 May 4.
6
[Non-verbal communication in patients with DM1 and FSHD].
Med Sci (Paris). 2018 Nov;34 Hors série n°2:9-12. doi: 10.1051/medsci/201834s203. Epub 2018 Nov 12.
7
Scapular dyskinesis in myotonic dystrophy type 1: clinical characteristics and genetic investigations.
J Neurol. 2019 Dec;266(12):2987-2996. doi: 10.1007/s00415-019-09494-8. Epub 2019 Aug 31.
9
Chronic pain has a strong impact on quality of life in facioscapulohumeral muscular dystrophy.
Muscle Nerve. 2018 Mar;57(3):380-387. doi: 10.1002/mus.25991. Epub 2017 Nov 7.
10
Prevalence and correlates of apathy in myotonic dystrophy type 1.
BMC Neurol. 2015 Aug 22;15:148. doi: 10.1186/s12883-015-0401-6.

引用本文的文献

1
Mouse models of non-dystrophic and dystrophic myotonia exhibit nociplastic pain-like behaviors.
bioRxiv. 2024 Jun 22:2024.06.19.599732. doi: 10.1101/2024.06.19.599732.
2
Small and large fiber neuropathy in adults with myotonic dystrophy type 1.
Front Neurol. 2024 Mar 5;15:1375218. doi: 10.3389/fneur.2024.1375218. eCollection 2024.
3
Pain and Motor Function in Myotonic Dystrophy Type 1: A Cross-Sectional Study.
Int J Environ Res Public Health. 2023 Mar 23;20(7):5244. doi: 10.3390/ijerph20075244.
4
Is Chronic Pain Temporal Pattern Associated with Middle-Aged and Older Adults' Perceptions of their Futures?
Health Psychol Bull. 2021;5(1):136-144. doi: 10.5334/hpb.34. Epub 2021 Dec 30.
6
Pain in adult myotonic dystrophy type 1: relation to function and gender.
BMC Neurol. 2021 Mar 4;21(1):101. doi: 10.1186/s12883-021-02124-9.
7
Digital Pain Mapping and Tracking in Patients With Chronic Pain: Longitudinal Study.
J Med Internet Res. 2020 Oct 26;22(10):e21475. doi: 10.2196/21475.
8
A role for cannabinoids in the treatment of myotonia? Report of compassionate use in a small cohort of patients.
J Neurol. 2020 Feb;267(2):415-421. doi: 10.1007/s00415-019-09593-6. Epub 2019 Oct 26.
9
Patient-Reported Symptoms in Facioscapulohumeral Muscular Dystrophy (PRISM-FSHD).
Neurology. 2019 Sep 17;93(12):e1180-e1192. doi: 10.1212/WNL.0000000000008123. Epub 2019 Aug 13.
10
Quality of life in adults with muscular dystrophy.
Health Qual Life Outcomes. 2019 Jul 15;17(1):121. doi: 10.1186/s12955-019-1177-y.

本文引用的文献

2
Rehabilitation of the muscular dystrophies.
Handb Clin Neurol. 2013;110:471-81. doi: 10.1016/B978-0-444-52901-5.00040-X.
3
Effects of pain and fatigue on physical functioning and depression in persons with muscular dystrophy.
Disabil Health J. 2012 Oct;5(4):277-83. doi: 10.1016/j.dhjo.2012.07.002. Epub 2012 Aug 4.
4
Disease burden in neuromuscular disease: the role of chronic pain.
Phys Med Rehabil Clin N Am. 2012 Aug;23(3):719-29. doi: 10.1016/j.pmr.2012.06.004.
5
Exercise in neuromuscular diseases.
Phys Med Rehabil Clin N Am. 2012 Aug;23(3):653-73. doi: 10.1016/j.pmr.2012.06.001.
7
Patient-reported impact of symptoms in myotonic dystrophy type 1 (PRISM-1).
Neurology. 2012 Jul 24;79(4):348-57. doi: 10.1212/WNL.0b013e318260cbe6. Epub 2012 Jul 11.
8
Quality of life and measures of quality of life in patients with neuromuscular disorders.
Muscle Nerve. 2012 Jul;46(1):9-25. doi: 10.1002/mus.23245. Epub 2012 May 29.
9
Exercise and Duchenne muscular dystrophy: where we have been and where we need to go.
Muscle Nerve. 2012 May;45(5):746-51. doi: 10.1002/mus.23244.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验